| Description | Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease. |
| molecular weight | 320.38 |
| Molecular formula | C17H24N2O4 |
| CAS | 866245-79-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 5 mg/mL (15.61 mM) |
| References | 1. Han J, Jiang S, Cui X, Sun Y, Li G, Zhang J, Fawcett JP, Gu J. Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2009 Sep 8;50(2):171-4. doi: 10.1016/j.jpba.2009.03.022. Epub 2009 Apr 1. PubMed PMID: 19395215. |
Octahydroaminoacridine succinate
CAS No.: 866245-79-6
Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer'
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.